These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9845497

  • 1. Failures of zidovudine postexposure prophylaxis.
    Jochimsen EM.
    Am J Med; 1997 May 19; 102(5B):52-5; discussion 56-7. PubMed ID: 9845497
    [Abstract] [Full Text] [Related]

  • 2. Zidovudine toxicity in uninfected healthcare workers. Italian Registry of Antiretroviral Prophylaxis.
    Ippolito G, Puro V.
    Am J Med; 1997 May 19; 102(5B):58-62. PubMed ID: 9845498
    [Abstract] [Full Text] [Related]

  • 3. Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers.
    D'Amico R, Pinto LA, Meyer P, Landay AL, Harris AA, Clerici M, Berzofsky JA, Shearer GM, Kessler HA.
    Infect Control Hosp Epidemiol; 1999 Jun 19; 20(6):428-30. PubMed ID: 10395147
    [Abstract] [Full Text] [Related]

  • 4. Assessment of adverse events associated with antiretroviral regimens for postexposure prophylaxis for occupational and nonoccupational exposures to prevent transmission of human immunodeficiency virus.
    Luque A, Hulse S, Wang D, Shahzad U, Tanzman E, Antenozzi S, Smith B.
    Infect Control Hosp Epidemiol; 2007 Jun 19; 28(6):695-701. PubMed ID: 17520543
    [Abstract] [Full Text] [Related]

  • 5. Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen.
    Beltrami EM, Luo CC, de la Torre N, Cardo DM.
    Infect Control Hosp Epidemiol; 2002 Jun 19; 23(6):345-8. PubMed ID: 12083242
    [Abstract] [Full Text] [Related]

  • 6. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group.
    Tokars JI, Marcus R, Culver DH, Schable CA, McKibben PS, Bandea CI, Bell DM.
    Ann Intern Med; 1993 Jun 15; 118(12):913-9. PubMed ID: 8387737
    [Abstract] [Full Text] [Related]

  • 7. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
    U.S. Public Health Service.
    MMWR Recomm Rep; 2001 Jun 29; 50(RR-11):1-52. PubMed ID: 11442229
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus in traveling health care workers.
    Uslan DZ, Virk A.
    J Travel Med; 2005 Jun 29; 12(1):14-8. PubMed ID: 15996462
    [Abstract] [Full Text] [Related]

  • 10. Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry.
    Wang SA, Panlilio AL, Doi PA, White AD, Stek M, Saah A.
    Infect Control Hosp Epidemiol; 2000 Dec 29; 21(12):780-5. PubMed ID: 11140914
    [Abstract] [Full Text] [Related]

  • 11. Use of HIV Postexposure Prophylaxis in healthcare workers after occupational exposure: a Thai university hospital setting.
    Kiertiburanakul S, Wannaying B, Tonsuttakul S, Kehachindawat P, Apivanich S, Somsakul S, Malathum K.
    J Med Assoc Thai; 2006 Jul 29; 89(7):974-8. PubMed ID: 16881429
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Investigations of possible failures of postexposure prophylaxis following occupational exposures to human immunodeficiency virus.
    Jochimsen EM, Luo CC, Beltrami JF, Respess RA, Schable CA, Cardo DM.
    Arch Intern Med; 1999 Oct 25; 159(19):2361-3. PubMed ID: 10547177
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HIV postexposure prophylaxis: Who should get it?
    Campos-Outcalt D.
    J Fam Pract; 2006 Jul 25; 55(7):600-4. PubMed ID: 16822447
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD, Holtgrave DR, Pinkerton HJ.
    Arch Intern Med; 1997 Sep 22; 157(17):1972-80. PubMed ID: 9308509
    [Abstract] [Full Text] [Related]

  • 18. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1996 Jun 07; 45(22):468-80. PubMed ID: 8622618
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Significant intolerability of efavirenz in HIV occupational postexposure prophylaxis.
    Wiboonchutikul S, Thientong V, Suttha P, Kowadisaiburana B, Manosuthi W.
    J Hosp Infect; 2016 Apr 07; 92(4):372-7. PubMed ID: 26876748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.